Novel prophylactic anticoagulation scoring tool helps stratify patients following lower limb trauma
1. The 3-month symptomatic venous thromboembolism rate was 0.7% in patients with TRiP(cast) score < 7 and not receiving anticoagulation. ...
Tag: venous thromboembolism (VTE)
Adulthood Atopic Dermatitis Associated With Venous Thromboembolism
1. Adulthood atopic dermatitis (AD) was significantly associated with an increased risk of venous thromboembolism (VTE); however, the absolute risk ...
Low-dose low-molecular weight heparin comparable to intermediate-dose for risk of venous thromboembolism in peripartum women
1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight ...
Aspirin associated with significantly higher rate of symptomatic venous thromboembolism compared to enoxaparin in patients undergoing hip or knee arthroplasty – the CRISTAL randomized trial
1. In this randomized controlled trial that included 9711 patients undergoing hip or knee arthroplasty, treatment with aspirin vs enoxaparin ...
![siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/04/clot-CCWiki-350x250.jpg)
Routine primary thromboprophylaxis with enoxaparin safe in children with COVID-19 or MIS-C
1. Routine use of prophylactic twice-daily enoxaparin demonstrated adequate safety in children with acute COVID-19 and multisystem inflammatory syndrome in children ...
SARS-CoV-2 infection during pregnancy associated with severe maternal morbidity, preterm birth, and venous thromboembolism
1. In a large longitudinal, population-based cohort study, SARS-CoV-2 infection during pregnancy was associated with severe maternal morbidity, preterm birth, ...
Venous thromboembolism rates in hospitalized children continue to rise
1. In a large retrospective study, rates of venous thromboembolism (VTE) in pediatric patients increased from 46 to 106 per ...
Rivaroxaban prophylaxis improves clinical outcomes in high-risk patients hospitalized with COVID-19
1. The primary efficacy outcome of symptomatic and asymptomatic venous thromboembolism was significantly lower in the rivaroxaban group (3.14%) compared ...
The use of a diagnostic strategy with age-adjusted D-dimer thresholds was non-inferior in risk-stratifying for thromboembolic events in emergency department patients with suspected pulmonary embolism
1. Compared to conventional diagnostic strategy, the use of the YEARS rule combined with the age-adjusted D-dimer threshold did not ...